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Abstract
Background: Associations between metabolic syndrome (MetS) and osteoporotic fracture have been reported.
However, the epidemiological studies are not conclusive. The objective of the study was to determine whether
metabolic syndrome associates with osteoporotic fracture.
Methods: This was a cross-sectional study of 9930 Chinese adults aged 40 year or older in the Chongming District,
Shanghai, China. A questionnaire, anthropometric measurements and laboratory tests were conducted. MetS was
defined according to the updated National Cholesterol Education Program Adult Treatment Panel III criteria for
Asian-Americans. A history of fractures was collected with an interviewer-assisted questionnaire. Osteoporotic
fractures were defined as fractures that occurred due to low-trauma in 2 years prior to the study.
Results: Among women, the prevalence of osteoporotic fractures was significantly higher in those with MetS
(3.5 vs. 2.6 %, P =0.028). However, the difference was not found in men (2.6 vs. 2.4 %, P =0.737). The presence of
Mets was significantly associated with increased odds of osteoporotic fracture among women (odds ratio 1.22; 95 %
confidence interval 1.12–1.54; P = 0.039) after controlling for potential confounders. The significant associations were
not detected in men.
Conclusions: The presence of MetS was significantly associated with a recent history of osteoporotic fracture
in middle-aged and elderly Chinese women.
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What’s new?
✓ In this study we found the presence of MetS was
significantly associated with a recent history of
osteoporotic fracture in a large sample of middle-
aged and elderly Chinese women.
✓ We found central obesity seem to have the strongest
associations with prevalence of osteoporotic facture
in women.
✓ Our study indicated bone metabolism seems to be
more markedly affected in women than in men with
metabolic syndrome.
Background
With the rapid economic growth and the ageing of its
population in China, osteoporosis has become one of
the most prevalent and debilitating chronic diseases. It
has often been called “the silent epidemic” because bone
loss is a slow asymptomatic process. Only when frac-
tures occur does the disease become symptomatic.
Recently, osteoporotic fracture has become an in-
creasingly important problem in elderly populations
and place a progressively heavy burden on health ser-
vices [1, 2]. Nutritional, lifestyle, hormonal, metabolic,
and genetic factors contribute to the occurrence of
osteoporotic fracture [2].
Metabolic syndrome (MetS) is a cluster of cardiovas-
cular risk factors has been defined as central obesity,
hypertension, impaired glucose tolerance, and dyslipid-
emia (specifically hypertriglyceridemia, along with low
levels of high-density lipoprotein cholesterol [HDL-c]).
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It is a public health problem because about 30–50 % of
the middle-aged and elderly people has MetS in China
[3, 4]. MetS is associated with a higher risk of cardiovas-
cular morbidity and mortality and a higher risk of onset
of type 2 diabetes. Although the relationship between
cardiovascular disease and osteoporosis has been widely
studied, the particular association between metabolic
syndrome, a strong risk factor for cardiovascular disease,
and osteoporotic fractures has not been so extensively
addressed and present several studies results were incon-
sistent [5–15]. Epidemiological studies on fracture inci-
dence or prevalence are therefore needed in order to
show the real pattern of fractures in MetS. In addition,
because metabolic syndrome consists of several single
components that could have their own independent rela-
tionship with osteoporosis, the possible association of
each of them with the osteoporotic fracture is also worth
considering.
Thus, the present study intended to evaluate the as-
sociation between MetS and osteoporotic fracture in a
population-based survey of middle-aged and elderly
Chinese people in Shanghai, China. We also examined
the association of each of the individual components
of metabolic syndrome with osteoporotic fracture.
Methods
Study population and design
In 2011 China a national survey of Risk Evaluation of
cAncers in Chinese diabeTic Individuals: a lONgitudinal
(REACTION) study, which was conducted among
259,657 adults, aged 40 years and older in 25 communi-
ties across mainland China, from 2011 to 2012 [16]. The
data presented in this article are based on the baseline
survey of subsamples from Shanghai in eastern China.
All studied individuals came from the Chongming
District in Shanghai, China [17–19]. Written consent
was obtained from all the participants. The protocol
was approved by the Ethics Committee of Xinhua
Hospital Affiliated to Shanghai Jiaotong University
School of Medicine.
Data collection
A standardized questionnaire was used by trained
physicians to collect information such as age, sex,
medications [17–19]. The methods of biochemical
measurements refer as previous studies [17–19]. Physical
activity at leisure time was estimated using the short form
of the International Physical Activity Questionnaire by
adding questions on frequency and duration of moderate
and vigorous activities and walking [20]. For evaluation of
total physical activity, separate metabolic equivalent hours
per week (MET-h/wk) were calculated.
Anthropometric measurements were performed by the
trained personnel using a standardized protocol [17–19].
BMI was calculated as body weight in kilograms divided
by height squared in meters. The abbreviated Modifica-
tion of Diet in Renal Disease formula recalibrated for
Chinese [21].
Definition of MetS
The MetS was defined based upon the updated
NCEP-ATPIII for Asian Americans as presenting 3 or
more of the following components: 1) waist cirumfer-
ence ≥90 cm for men or ≥80 cm for women; 2) triglycer-
ides ≥1.7 mmol/l; 3) HDL cholesterol <1.03 mmol/l for
men or <1.30 mmol/l for women; 4) blood pressure ≥130/
85 mm Hg or current use of anti-hypertensive medica-
tions; and 5) fasting glucose ≥5.6 mmol/l or previously di-
agnosed type 2 diabetes or on oral antidiabetic agents or
insulin [22].
Assessment of fractures
With an interviewer-assisted questionnaire, we collected
information about the history of fractures. Fracture sites
and the age of the participants when they had fractures
were recorded. For the current study, osteoporotic frac-
tures were defined as fractures that occurred due to low
trauma in the 2 yr before the study [23]. All fractures
that were considered to be nonosteoporotic (i.e. frac-
tures due to cancer or an accident, such as a motor ve-
hicle accident, and all fractures of the fingers, faces,
skull, and toes) were excluded [24].
Statistical analysis
The statistical analysis was conducted using SPSS (ver-
sion 13.0, SPSS Inc., Chicago, Illinois). Because sex is an
important confounding factor of osteoporotic fractures,
we performed analyses separately in men and women
[25]. The following skewed variables were normalized by
logarithmic transformation before analyses in which they
were treated as continuous variables: TG, eGFR and
MET-h/wk. All continuous variables were presented as
means ± SD or medians (inter-quartile ranges), and all
categorical variables were presented as proportions. The
t test and Chi-square test were used to examine differ-
ences in continuous and categorical variables, respect-
ively. To investigate the associations between metabolic
syndrome and osteoporotic fracture, the unadjusted and
multivariate adjusted logistic regression analyses were
used to assess odds ratios (OR) and corresponding
95 % confidence intervals (CI). The statistical tests
were two sided, and a P < 0.05 was considered statisti-
cally significant.
Results
Among the 9930 participants, the mean (±SD) age was
56.2 ± 7.8 yr, 32.5 % were men. The overall prevalence of
osteoporotic fracture was 2.9 % (2.5 % in men and 3.1 %
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in women). The skeletal sites of the most common frac-
tures were wrist in men (22.2 % of all fractures, n = 18)
and ankle in women (20.2 % of all fractures, n = 42).
The clinical and biochemical characteristics stratified
by metabolic syndrome status are shown for men and
women in (Additional file 1: Table S1A and S1B). In
men, participants with metabolic syndrome were older,
more likely to be obese, and had significantly higher
levels of TG, LDL-c, fasting plasma glucose (FPG), post-
prandial 2-h plasma glucose (PPG), HbA1c, waist cir-
cumference (WC), Hip circumference (HC), waist to hip
ratio (WHR) and alcohol consumption habits and lower
levels of HDL-c and eGFR (all p < 0.01). There was no
significant difference between the two groups for TC,
physical activity (MET-h/wk), and smoking. Similarly, in
women, higher levels of age, BMI, WC, HC, WHR, TG,
LDL-c, FPG, PPG, and alcohol consumption habits and
lower levels of HDL-c were found in those with meta-
bolic syndrome (all p < 0.05). Women with metabolic
syndrome were less likely to be postmenopausal. How-
ever, the levels of serum TC in women with metabolic
syndrome were higher in comparison with those without
metabolic syndrome (p < 0.0001).
We further investigate the prevalence of osteoporotic
fractures according to metabolic syndrome status for
men and women. Among women, the prevalence of
osteoporotic fractures was significantly higher in those
with metabolic syndrome (3.5 vs. 2.6 %, P =0.028).
However, the difference was not found in men (2.6 vs.
2.4 %, P =0.737).
As shown in Table 1, the presence of metabolic syn-
drome was significantly associated with increased odds
of osteoporotic fracture among women (OR 1.38; 95 % CI
1.04–1.85; P =0.028). Further adjustment for age, smoking
and alcohol consumption habits (yes/no), physical ac-
tivity (MET-h/wk), eGFR, BMI, waist circumference
and hip circumference, TG, TC, HDL-c, LDL-c, dia-
betes status (yes/no), FPG, HbA1c, menopause status
(yes/no) and hormone replacement (yes/no) treatment
did not materially change the association (OR 1.22;
95 % CI 1.12–1.54; P = 0.039). However, the signifi-
cant associations were not detected in men.
Tables 2 and 3 shows that Ors for the fracture risk
calculation according to increasing numbers of the
metabolic syndrome by ATPIII and IDF criteria. The
fracture risk significantly increased according to in-
creasing numbers of the metabolic syndrome by
ATPIII and IDF criteria in women, but not in men.
Table 4 shows the ORs for individual components
of metabolic syndrome by NCEP-ATPIII for Asian as-
sociated with osteoporotic fractures. Of the five MetS
components, hypertension and central obesity seem to
have the positive associations with risk of osteopor-
otic fractures in women.
Discussion
In this study, we found that the presence of MetS was
significantly associated with a recent history of osteopor-
otic facture in women aged 40 yr or older. Moreover,
this association was independent of other potential trad-
itional risk factors.
Metabolic syndrome (MetS) is a cluster of cardiovas-
cular risk factors which have been grouped under this
name because they coexist much more often than would
be expected by chance. Whether it is a real clinical entity
or not is the subject of much controversy, but in any
case, apart from its cardiovascular consequences, a pos-
sible relationship with bone mass has been entertained
[26–28]. Furthermore, some common mechanisms for
both disorders have been proposed. For instance, low
vitamin D levels are considered predisposing factors for
osteoporosis, and have also been suggested to facilitate
the development of MetS [29–32]. In addition, few stud-
ies have presented increased prevalence of osteoporosis
fractures in subjects with MetS [11, 12]. In our study,
after adjusted for potential cofounders, a positive associ-
ation between MerS and a recent history of osteoporotic
fracture was detected.
Our study indicated bone metabolism seems to be
more markedly affected in women than in men with
metabolic syndrome. The differences between men and
women in bone structure and strength, body fat depos-
ition, sex hormone levels, and risk of falls could be po-
tential explanations for the inconsistency of associations
between osteoporotic fracture and MetS by genders [32].
Potential sex-specific associations of MetS with osteo-
porotic fracture need to be elucidated further. Our find-
ings lend support to the postulation that the presence of
Table 1 Association between metabolic syndrome and a recent
history of osteoporotic fracture
Men Women
OR (95 % CI) P value OR (95 % CI) P value
unadjusted 1.08 (0.70–1.68) 0.737 1.38 (1.04–1.85) 0.028
Model 1 0.96 (0.73–1.57) 0.596 1.25 (1.02–1.69) 0.031
Model 2 0.87 (0.68–1.44) 0.264 1.20 (1.02–1.57) 0.034
Model 3 1.00 (0.74–1.36) 0.986 1.23 (1.09–1.45) 0.038
Model 4 1.00 (0.73–1.36) 0.991 1.21 (1.11–1.42) 0.038
Model 5 1.01 (0.75–1.61) 0.784 1.18 (1.13–1.39) 0.039
Model 6 1.20 (1.11–1.53) 0.040
We defined participants without osteoporotic fractures as 0 and those with
osteoporotic fractures as 1. Model 1 was adjusted for age, smoking and alcohol
consumption habits (yes/no), physical activity (MET-h/wk), and eGFR. Model 2
was further adjusted for BMI, waist circumference and hip circumference based
on model 1. Model 3 was further adjusted for serum TG, TC, HDL-c, and LDL-c
based on model 2. Model 4 was further adjusted for diabetes status (yes/no), FPG
and HbA1c based on model 3. Model5 was further adjusted for blood pressure
on model 4. Model 6 was further adjusted for menopause status (yes/no) and
hormone replacement (yes/no) treatment for women based on model 5
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metabolic syndrome in middle-aged and elderly Chinese
women may confer a higher osteoporotic fracture risk.
These findings suggest an awareness of the need to
screen women with MetS for the presence of osteopor-
osis in fracture prevention. Moreover, the potential con-
tribution of metabolic syndrome to development of
osteoporosis warrants further study. Furthermore, in
order to investigate whether other definition of the MetS
also confirm the finding, we have re-analyzed the results
by definition of the MetS (IDF 2005), similarly, we also
found that the presence of metabolic syndrome was sig-
nificantly associated with increased odds of osteoporotic
fracture among women. Simultaneously, we found he
prevalence of fracture significantly increased for those
with one to five components after adjustment for age,
gender (P trends < 0.05).
To study the possible independent relationship be-
tween the five components of metabolic syndrome and
osteoporotic facture, a logistic regression analysis was
performed. Hypertension and central obesity seem to
be the positive associations with risk of osteoporotic
fractures in women. Consistent with our results, previ-
ous studies have found higher blood pressure in elderly
women was associated with increased bone loss at the
femoral neck [33]. Moreover, low fracture risk was ob-
served among those using treatment for hypertension
although it was not significant [34]. Recently, a large-
scale case–control study have also demonstrated that
hypertension seem to be the major cardiovascular risk
factors for fractures [35]. Certainly, as most fractures
occur in those elderly people and blood pressure in-
creases with age, an increased risk of fractures for in-
creasing blood pressure should be expected. Therefore,
most available data point toward a positive association
between both parameters, even if the pathogenetic
mechanisms involved remain unclear.
We found central obesity seem to have the strongest
associations with prevalence of osteoporotic facture in
women. Although the pathophysiological mechanisms
linking central obesity to osteoporotic fracture have not
been well established, it is plausible to consider excessive
accumulation of visceral fat could result in a higher se-
cretion of proinflammatory cytokines, with a detrimental
effect on bone; in fact, a negative relation between fat
mass and bone mass for a given body weight has been
reported [36–38].
From few bone histology studies in humans and ex-
perimental studies there is evidence that a decreased
bone formation is one major mechanism leading to re-
duced bone mass in diabetics. Few studies address the
role of diabetes and osteroporosis [39, 40]. However, we
fail to replicate this results in our study. There is a need
for further longitudinal studies, including the incidence
and risk factors for osteoporotic fractures.
Several limitations of our study have to be addressed.
First, due to the cross-sectional nature of the current
study, admittedly, we could not determine whether
MetS plays a causal role in the pathogenesis of osteo-
porotic fracture. Further prospective population-based
studies are needed to clarify their precise interrelation-
ship. Second, because the information of osteoporotic
fracture is based on self-reports and no measurements
of bone mineral density by dual-energy x-ray absorpti-
ometry or other radiological methods were made, we
could not identify asymptomatic osteoporotic fractures.
Finally, although a wide spectrum of covariates were in-
cluded in the adjustment, some residual or undetected
confounding factors could not be ruled out, such as
dietary calcium intake or serum 25-hydroxyvitamin D3
levels, which are other factors affecting osteoporosis [41].
Conclusions
We have found that the presence of MetS was signifi-
cantly associated with a recent history of osteoporotic
fracture in middle-aged and elderly Chinese women.
Further longitudinal studies are expected to determine
Table 2 The fracture risk calculation according to increasing numbers of the metabolic syndrome (ATPIIIcriteria)
ORs (95 % CI)
Numbers of components of MetS 0 1 2 3 4 5 P value for trend
Men 1 0.98 (0.71–1.31) 0.96 (0.67–1.29) 1.02 (0.74–1.37) 1.02 (0.76–1.40) 1.11 (0.95–1.44) 0.127
Women 1 0.97 (0.69–1.32) 1.01 (0.78–1.41) 1.26 (1.02–1.67) 1.39 (1.09–1.74) 1.54 (1.23–2.17) 0.005
We defined participants without osteoporotic fractures as 0 and those with osteoporotic fractures as 1. Adjusted for age, smoking, alcohol consumption habits
(yes/no), physical activity (MET-h/wk), eGFR, BMI, menopause status (yes/no) and hormone replacement (yes/no) treatment for women
Table 3 The fracture risk calculation according to increasing numbers of the metabolic syndrome (IDF criteria)
ORs (95 % CI)
Numbers of components of MetS 0 1 2 3 4 5 P value for trend
Men 1 0.99 (0.72–1.32) 0.97 (0.69–1.30) 1.01 (0.75–1.36) 1.02 (0.75–1.39) 1.10 (0.94–1.43) 0.132
Women 1 0.98 (0.70–1.31) 1.02 (0.79–1.42) 1.28 (1.04–1.71) 1.42 (1.11–1.82) 1.58 (1.25–2.24) 0.002
We defined participants without osteoporotic fractures as 0 and those with osteoporotic fractures as 1. Adjusted for age, smoking, alcohol consumption habits
(yes/no), physical activity (MET-h/wk), eGFR, BMI, menopause status (yes/no) and hormone replacement (yes/no) treatment for women
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the role of MetS in the development of osteoporotic
fracture.
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